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Background: Diversity among human leukocyte antigen (HLA) molecules has been maintained by host-pathogen
coevolution over a long period of time. Reflecting this diversity, the HLA loci are the most polymorphic in the human
genome. One characteristic of HLA diversity is long-term persistence of allelic lineages, which causes trans-species
polymorphisms to be shared among closely related species. Modern humans have disseminated across the world
after their exodus from Africa, while chimpanzees have remained in Africa since the speciation event between humans
and chimpanzees. It is thought that modern humans have recently acquired resistance to novel pathogens outside
Africa. In the present study, we investigated HLA alleles that could contribute to this local adaptation in humans and
also studied the contribution of natural selection to human evolution by using molecular data.
Results: Phylogenetic analysis of HLA-DRB1 genes identified two major groups, HLA Groups A and B. Group A formed a
monophyletic clade distinct from DRB1 alleles in other Catarrhini, suggesting that Group A is a human-specific allelic
group. Our estimates of divergence time suggested that seven HLA-DRB1 Group A allelic lineages in humans have been
maintained since before the speciation event between humans and chimpanzees, while chimpanzees possess only
one DRB1 allelic lineage (Patr-DRB1*03), which is a sister group to Group A. Experimental data showed that some
Group A alleles bound to peptides derived from human-specific pathogens. Of the Group A alleles, three exist at
high frequencies in several local populations outside Africa.
Conclusions: HLA Group A alleles are likely to have been retained in human lineages for a long period of time and
have not expanded since the divergence of humans and chimpanzees. On the other hand, most orthologs of HLA
Group A alleles may have been lost in the chimpanzee due to differences in selective pressures. The presence of alleles
with high frequency outside of Africa suggests these HLA molecules result from the local adaptations of humans. Our
study helps elucidate the mechanism by which the human adaptive immune system has coevolved with pathogens
over a long period of time.
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Modern humans (Homo sapiens) live in a wide variety of
environments, ranging from polar to tropical regions.
Physiological anthropologists have long addressed the
issue of ‘human adaptation’ to a variety of environments
(that is the ability of humans to survive in a changing
environment). Molecular evolution and population
genetics also focus on the adaptation of humans to en-
vironmental changes. The approach of physiological
anthropology is mainly to investigate differences in* Correspondence: hyasukou@proof.ocn.ne.jp
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article, unless otherwise stated.physiological modifications among individuals or ethnic
groups in various environments (‘physiological poly-
morphism’) in order to understand human adaptation.
On the other hand, molecular evolution or population
genetics seek indications of natural selection by comparing
nucleotide sequences of a target gene. If a new mutation
at a target locus confers advantage for fitness in a certain
environment, such a mutation is expected to rapidly
spread throughout a population because of positive
natural selection. Methods to detect such a signal of
natural selection have been developed. For instance, in
a protein coding gene, an excess in the number of
non-synonymous substitutions (that change the amino
acid sequence) over synonymous substitutions (neutralCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
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selection has occurred during the evolution of the
target gene. In addition, the relationship between an
allelic frequency and the extent of linkage disequilibrium
(LD) around the selected mutation help us to find an allele
that has rapidly spread in a population [1]. The advan-
tageous allele is expected to dramatically increase its
frequency in a short time so that recombination does not
substantially break down the LD around the selected site.
Humans live in various environments around the
world. The endemic pathogens that humans are infected
by in these areas differ and humans have evolved to deal
with these pathogens. In the present study, we focus on
polymorphisms in the major histocompatibility complex
(MHC), which plays an important role in triggering
immune reactions in response to pathogens, and we
discuss the possibility that a human-specific MHC
allele is involved in the immunological adaptation to a
human-specific pathogen.
The MHC is a set of cell-surface molecules that are
responsible for presenting antigens from pathogens to
lymphocytes in jawed vertebrates. As such, it is an
important genetic system for protection against infec-
tious disease [2]. In humans, the MHC is termed human
leukocyte antigen (HLA). The HLA genomic region is
located on the short arm of chromosome 6 at 6p21.3,
spanning approximately 4 Mbp and comprising 224
genes [3]. The region is classified into three subregions:
class I, class II, and class III regions. Among HLA mole-
cules, six class I and II molecules (HLA-A, B, and C of
class I and HLA-DR, DQ, and DP of class II) are import-
ant for antigen presentation to T lymphocytes. Class I
molecules mainly bind to peptides from cytosolic proteins
and the HLA-peptide complex is recognized by CD8+ T
cells. Class II molecules present extracellular antigens to
CD4+ T cells. Class I molecules consist of two polypeptide
chains, an α heavy chain encoded in the class I region, and
a β2-microglobulin light chain encoded on chromosome
15. Class II molecules are composed of two polypeptide
chains, α and β chains, encoded in the class II region. For
instance, the DRA and DRB1 genes in the class II region
encode the α and β chains, respectively, of the DR mol-
ecule. A peptide-binding region (PBR) was characterized
with crystallography by Bjorkman et al. [4] for class I
HLA-A and by Brown et al. [5] for class II HLA-DR.
Molecular evolutionary studies of this region have revealed
an enhancement of non-synonymous substitutions in
the PBR, suggesting that the PBR is a target for balan-
cing selection, which is responsible for the maintenance
of HLA polymorphisms [6-10].
Polymorphisms in HLA genes have three unique fea-
tures: (1) a large number of alleles, (2) a high degree of
heterozygosity, and (3) remarkably long persistence time
of the allelic lineage. These features are maintained bybalancing selection but not by an increased mutation
rate [11,12].
The chimpanzee (Pan troglodytes) is the closest extant
relative of humans. Interestingly, chimpanzees appear to
have resistance to several pathogens to which humans are
susceptible, including HIV type 1 and human hepatitis B
virus [13]. This indicates that the two species differ in
their immune responses to these pathogens, and that pos-
sibly the pathogen recognition repertoire for MHC is dif-
ferent between the two species. Chimpanzees share some
class II DRB1 allelic lineages with humans [14-16]. In
humans, genetic variation and selective intensity on DRB1
are the greatest in the class II genes [17]. In humans, there
are 13 DRB1 allelic lineages (HLA-DRB1*01, *03, *04, *07,
*08, *09, *10, *11, *12, *13, *14, *15 and *16), while there
are only four allelic lineages (Patr-DRB1*02, *03, *07
and *10) in chimpanzees [14-16].
Chimpanzees have stayed in Africa since their diver-
gence from humans approximately six million years ago
(MYA). On the other hand, modern humans have dispersed
across the world from Africa from 100,000 to 50,000 years
ago and have adapted to regions with various exogenous
pathogens. This begs the question of how modern humans
have acquired resistance to a variety of pathogens in differ-
ent environments. Therefore, the present study investigated
the evolution of HLA-DRB1 alleles that confer resistance to
novel pathogens in humans. For this purpose, we studied
nucleotide sequences of HLA genes using the IMGT/HLA
database (http://www.ebi.ac.uk/imgt/hla/, [18]).
Materials and methods
Nucleotide sequences of humans, chimpanzees, rhesus
monkeys (Macaca mulatta), and crab-eating macaques
(Macaca fascicularis) were used for phylogenetic analyses.
A dataset of human DRB allele sequences, including
DRB1 and other functional DRB (DRB3, DRB4, and
DRB5), was obtained from the IMGT/HLA database. The
dataset of non-human primate DRB1 alleles was obtained
from the IPD MHC NHP database (http://www.ebi.ac.uk/
ipd/mhc/nhp/, [19]). In the database, there were many
partial coding sequences (CDS) (mainly exon 2 sequences).
Using incomplete sequences is likely to be misleading in
analysis of the phylogenetic relationships among sequences;
therefore, we performed phylogenetic analyses only for
full-length DRB1 CDS. Because only partial sequences
were available, we also excluded sequence data of the
gorilla (Gorilla gorilla) and orangutan (Pongo pygmaeus)
from the present analysis. We used two HLA-DQB1 alleles
as outgroup sequences. Next, we removed sequences of
potential recombinant alleles according to a method that
assumes a binomial distribution of the ratio of substitutions
in a particular region to that in the entire region [17,20-22].
For phylogenetic analyses, we used 104 complete CDS: 56
HLA-DRB1, 6 HLA-DRB3, 4 HLA-DRB4, 2 HLA-DRB5, 11
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and 3 crab-eating macaqueMafa-DRB1 alleles.
Brown et al. [5] identified 24 amino acids in the PBR
of HLA-DRB1 genes. In addition to the defined PBR, we
included three amino acid sites (positions of 57, 67, and
90; for a total of 27 amino acids), because Brown and
collaborators have subsequently shown that the three
sites are involved in the formation of peptide-binding
grooves and peptide binding [23].
Multiple sequence alignment of nucleotide sequences
and phylogenetic-tree construction were performed using
the MEGA v5.10 software [24]. A maximum likelihood
(ML) tree for the non-PBR region was constructed based
on the Hasegawa-Kishino-Yano (HKY) substitution model
[25] with the nearest-neighbor-interchange (NNI) ML
heuristic search. The best-fit substitution model was
estimated by MEGA. Bootstrap analysis was performed
using 1,000 replications. The numbers of non-synonymous
substitutions per non-synonymous site (dN) and synonym-
ous substitutions per synonymous site (dS) were calculated
using the modified Nei-Gojobori method [26] with a Jukes-
Cantor correction [27]. The transition/transversion bias
used in this calculation was estimated with the ML method
in MEGA. The average divergence time of DRB1 alleles
was estimated by the average of all pairwise dS values, and
the time to the most recent common ancestor (TMRCA)
of alleles was estimated from the maximum number of syn-
onymous substitutions per site (dSmax). The divergence time
was estimated by the following formula:
TMRCA ¼ dSmax=2μ
where μ is the neutral substitution rate of 10−9 per site
per year at the MHC loci [9]. Pathogens recognized by
HLA-DRB1 molecules were examined using the Immune
Epitope Database (IEDB) (http://www.immuneepitope.org,
[28]). Information about HLA-DRB1 allele frequency
among different human populations was collected from
the NCBI dbMHC database (http://www.ncbi.nlm.nih.
gov/gv/mhc, [29]).
Results and discussion
Two phylogenetic groups of HLA-DRB1 alleles and
human-specific HLA Group A
To examine phylogenetic relationships among DRB alleles
in four primate species (HLA-DRB1/3/4/5, Patr-DRB1,
Mamu-DRB1, and Mafa-DRB1), an ML tree was con-
structed from nucleotide sequences of the non-PBR region
(Figure 1). Nucleotide sequences in the PBR were excluded
for construction of the tree because they had an approxi-
mately ten-fold higher amino acid-altering (non-synonym-
ous) substitution rate than synonymous substitutions due
to balancing selection (Hughes and Nei [6,7]; Takahata and
Nei [11]). When we focused on HLA-DRB1 alleles, weidentified two distinct clades in the ML tree. We refer to
these two groups as HLA Group A and HLA Group B. Of
the 13 known HLA allelic lineages, seven lineages, including
DRB1*03, *08, *10, *11, *12, *13, and *14, were assigned to
Group A, while the remaining six lineages, DRB1*01, *04,
*07, *09, *15, and *16, were assigned to Group B.
In the ML tree, the Group B alleles showed trans-species
evolution of polymorphisms with those in the chimpanzee
(Patr-DRB1*02 and *07). Interestingly, 31 Group A alleles
formed a monophyletic clade distinct from other primate
DRB1 alleles, although the bootstrap value for supporting
this cluster was not particularly high, suggesting that
the Group A alleles are human-specific. Previous studies
[14-16] have not identified this DRB1 monophyletic group
in humans, because the nucleotide sequences used in
those studies were limited to exon 2.
Both the mean and maximal dS values were larger in
Group B (mean dS, 0.041; dSmax, 0.082) than in Group A
(mean dS, 0.018; dSmax, 0.057) (Table 1). This indicates
that most allelic lineages in Group B have been maintained
for a longer time than those in Group A. Additionally,
Group A alleles may have diverged more recently than
Group B alleles. Based on these results, we propose two
hypotheses for the monophyly of Group A: (1) Group A
alleles specifically expanded in the human lineage or (2)
the orthologs to Group A alleles were lost in chimpanzees.
We estimated the divergence time for alleles in each group
in order to test these hypotheses.
Divergence time of alleles in HLA Groups A and B
The phylogeny showed a difference in divergence time
between Groups A and B. The mean divergence times
for Groups A and B were approximately 9 and 21 MYA,
respectively, and TMRCAs were approximately 29 and
41 MYA, respectively (Table 1). These values suggest the
presence of specific trans-species polymorphisms [10,30,31]
in both groups, because the mean divergence time
exceeded the speciation time of humans and chimpanzees
[32-34]. Based on this result, we rejected the hypoth-
esis that the HLA Group A allelic lineages specifically
expanded in humans. However, the tree revealed that
alleles in Group A did not intermingle with other non-
human primate DRB1 alleles (Figure 1). The closest
was the Patr-DRB1*03 lineage cluster (indicated by an
arrow in Figure 1).
Furthermore, we estimated the TMRCA of Patr-DRB1*03
cluster to be 4.6 MYA (Figure 2), suggesting that the alleles
in this cluster diverged in chimpanzees after their diver-
gence from humans. Accordingly, only one allelic lineage
leading to the cluster in extant chimpanzees existed in the
common ancestral population of humans and chimpanzees.
On the other hand, in humans, pairwise dS distances
between HLA-DRB1 alleles suggested that seven allelic
lineages existed in the ancestral population (Figure 2).
Figure 1 Maximum likelihood tree for nucleotide sequences (690 bp) in the non-peptide-binding region (PBR) of MHC DRB alleles. The
sequence data of MHC DRB alleles, including those of humans, chimpanzees, and macaques, were obtained from IMGT/HLA and IPD databases.
HLA-DRB1 alleles are indicated in bold. Arrow indicates the Patr-DRB1*03 lineage, which is a sister group of HLA Group A alleles. Only bootstrap
values > 80% are shown. Two HLA-DQB1 sequences were used as an outgroup. The evolutionary distances were computed using the
Hasegawa-Kishino-Yano (HKY) model. HLA Group A and HLA Group B indicate two major phylogenetic groups of HLA-DRB1 alleles. HLA, humans;
Patr, chimpanzees; Mamu, rhesus monkeys; Mafa, crab-eating macaques.
Table 1 The divergence time of the two HLA groups,
HLA-Group A and HLA-Group B
dS (mean) T dS (max) TMRCA
Group A 0.018 9 MYA 0.057 29 MYA
Group B 0.041 21 MYA 0.082 41 MYA
T indicates the mean divergence time of alleles. TMRCA indicates the time to
the most recent common ancestor of alleles.
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sessed at least eight allelic lineages.
Although alleles in Group A formed a single clade in
the ML tree of primate DRB alleles, the TMRCA was 29
MYA, which is significantly older than six MYA (that is
the speciation time of humans and chimpanzees). Thus, the
molecular clock for DRB1 alleles may have been skewed by
various factors, such as back or parallel mutations (multiple
mutations) or recombination/gene conversion. Indeed, in
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Figure 2 Divergence times of HLA Group A and Patr-DRB1*03 alleles. The dashed line represents the speciation event of humans and
chimpanzees. Times to most recent common ancestor (TMRCAs) were estimated based on the maximum genetic distance at synonymous sites (dSmax).
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with a unique nucleotide observed only once in the
sampled alleles, and 11 were phylogenetically inform-
ative sites. Among 55 pairs of 11 informative sites, 13
pairs were phylogenetically incompatible with each other.
This incompatibility was likely the result of either recom-
bination/gene conversion or multiple mutations at a single
site. In the event of recombination/gene conversion, how-
ever, double recombination in a relatively small region or
a conversion tract with a small size should be considered.
Multiple mutations are a more likely cause of this incom-
patibility. To examine whether the presence of multiple
substitutions masked an accurate estimate of the TMRCA,
we tested the accuracy of the correction for multiple sub-
stitutions in the calculation of dSmax.
For this purpose, we estimated the maximum number
of synonymous substitutions in a different way. First, we
placed synonymous substitutions observed in the Group
A alleles on each branch of the ML tree parsimoniously
(Figure 1 and Additional file 1: Figure S1) and re-counted
the number of synonymous substitutions (KS) in eachpair of Group A alleles. The maximum KS was thirteen
(KSmax = 13). TMRCA was calculated from this KSmax
divided by the mean number of synonymous sites (LS =
223). As a result, the TMRCA of the Group A alleles was
estimated to be 29 MYA. This showed good agreement
with the TMRCA estimated by the Jukes-Cantor correc-
tion (29 MYA). Because there was no bias in our method
of estimating TMRCA, we considered it to be reliable.
Probability of maintaining seven human-specific HLA
Group A allelic lineages over six million years
A method for calculating the probability, gnk(t) [35], that
there were k allelic lineages among n extant lineages for
t in N generations under balancing selection is available.
In the present study, we tried to calculate the probability
gnk(t) for seven ancestral allelic lineages being maintained
since approximately six MYA among a sample of 31
Group A alleles (n = 31). However, because HLA-DRB1
also contains the 25 Group B alleles, the 31 Group A
sequences are only a part of the samples in the entire
HLA-DRB1. There were no means to determine the
Table 2 The comparison of specific pathogen bound by HLA-DRB1 molecules between Group A and Group B
Source organism ID Source organism name HLA-DRB1 molecule
520 Bordetella pertussis HLA-DRB1*11:01 Group A
1309 Streptococcus mutans HLA-DRB1*08:02
6956 Dermatophagoides pteronyssinus HLA-DRB1*11:01
10408 Hepatitis B virus subtype adw2 HLA-DRB1*12:01
10580 Human papillomavirus type 11 HLA-DRB1*03:01
11234 Measles virus HLA-DRB1*11:01, 11:03
206203 Influenza B virus [B/Hong Kong/330/2001] HLA-DRB1*14:01
385630 Influenza A virus [A/Bangkok/1/1979(H3N2)] HLA-DRB1*12:01
387161 Influenza A virus [A/Japan/305/1957(H2N2)] HLA-DRB1*11:01, 11:02, 11:03, 11:04
10000974 Streptococcus mutans GS-5 HLA-DRB1*08:02
210 Helicobacter pylori HLA-DRB1*04:01, 15:01 Group B
236 Brucella ovis HLA-DRB1*04:01, 04:07
562 Escherichia coli HLA-DRB1*04:01, 07:01, 15:01
1313 Streptococcus pneumoniae HLA-DRB1*15:01
1358 Lactococcus lactis HLA-DRB1*04:01, 04:07
1423 Bacillus subtilis HLA-DRB1*15:01
1764 Mycobacterium avium HLA-DRB1*15:01
4479 Poaceae HLA-DRB1*15:01
10254 Vaccinia virus WR HLA-DRB1*04:01
10309 Herpes simplex virus (type 1/strain SC16) HLA-DRB1*04:01, 15:01
10957 Human rotavirus strain P HLA-DRB1*04:01, 04:04, 15:01
11309 Unidentified influenza virus HLA-DRB1*04:01
11679 HIV type 1 (CLONE 12) HLA-DRB1*09:01
11694 HIV virus type 1 (JH3 ISOLATE) HLA-DRB1*09:01, 15:01
12721 HIV HLA-DRB1*01:03
130763 Influenza A virus [A/Hong Kong/156/97(H5N1)] HLA-DRB1*09:01
197911 Influenza virus A HLA-DRB1*04:01, 04:05
211044 Influenza A virus [A/Puerto Rico/8/1934(H1N1)] HLA-DRB1*04:01, 04:05
243160 Burkholderia mallei ATCC 23344 HLA-DRB1*04:01
351073 Mammalian orthoreovirus HLA-DRB1*04:01, 15:01
381512 Influenza A virus [A/New Caledonia/20/1999(H1N1)] HLA-DRB1*04:01
381513 Influenza A virus [A/Panama/2007/1999(H3N2)] HLA-DRB1*04:01
382781 Influenza A virus [A/Singapore/1/1957(H2N2)] HLA-DRB1*09:01
641501 Influenza A virus [A/California/04/2009(H1N1)] HLA-DRB1*04:01
746128 Aspergillus fumigatus HLA-DRB1*15:01, 15:02
768646 Influenza A virus [A/chicken/Uchal/8293/2006(H9N2)] HLA-DRB1*09:01
768647 Influenza A virus [A/chicken/Uchal/8286/2006(H9N2)] HLA-DRB1*09:01
991335 Influenza A virus [A/swine/Hong Kong/71/2009(H1N1)] HLA-DRB1*09:01
The dataset of source organism bound to HLA-DRB1 molecules was acquired from the MHC binding assay in the IEDB database.
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which was required for the calculation of gnk(t); therefore,
we could not calculate the probability of maintaining the
current Group A alleles for six million years.
The effective population size Ne of modern humans is
smaller than that of chimpanzees [36-38], and the eightallelic lineages in the ancestral population have likely been
lost more frequently from the human lineage than the
chimpanzee lineage. Nevertheless, the number of allelic
lineages in humans is seven times larger than that in
chimpanzees. This supports the hypothesis that natural
selection selectively maintained Group A alleles in humans.
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these seven lineages have been maintained only in humans.
Specific peptides bound to HLA Group A alleles
It is possible that the HLA Group A allelic lineages have
been because they bind to peptides derived from human-
specific pathogens. Thus, we examined pathogens and
their specific peptides recognized by each of the Group A
and B allelic lineages based on information of experimen-
tal data from the IEDB database (Table 2). There were ten
pathogens that produced peptides bound only by Group
A alleles (for example, human papillomavirus type 11
(HPV-11) and influenza B virus (IBV)), and some of them
were candidates for human-specific pathogens. In fact, in
addition to HPV-11, Bordetella pertussis and measles
viruses have been reported to be human-specific patho-
gens [39,40] (Table 2). Moreover, the IBV is restricted to
humans with the exception of an infection identified in
seals stranded on the Dutch coast [41]. At present,
however, the repertoire of peptides bound by each allele
is limited in the experimental data. Future studies will
establish whether chimpanzees and macaques MHC are
able to bind HLA Group A-specific peptides.
In HLA Group B, although some pathogens infect not
only humans but also other animals (for example, Brucella
ovis and Burkholderia mallei), candidates for human-
specific pathogens (for example, Helicobacter pylori) were
included. This suggests that some Group B alleles might
be also involved in local adaptation in humans.
The frequency distributions of eight HLA-DRB1 alleles
(HLA-DRB1*0301, *08:02, *11:01, *11:02, *11:03, *11:04,
*12:01, and *14:01) that recognize Group A-specific
pathogens were investigated using information in the
NCBI dbMHC database (Additional file 2: Figure S2).
The frequency distributions of HLA-DRB1*08:02, *12:01,
and *14:01 were high outside Africa, suggesting that the
frequency of the DRB1 molecules might have increased
since the human species disseminated outside Africa.
Chimpanzees appear to have lost a relatively large
number of alleles from the Group A allelic lineage while
humans have maintained several allelic lineages since
their speciation. The examination of genetic variation in
MHC class I Patr-A, Patr-B, and Patr-C loci suggested
that the genetic variations in chimpanzees have been
severely reduced [42]. In this previous study, it was
hypothesized that a selective sweep caused the loss of
genetic diversity at MHC loci in chimpanzees in order
to avoid widespread viral infection, such as that with
chimpanzee-derived simian immunodeficiency virus,
prior to a subspeciation of the common chimpanzee
and bonobo (Pan paniscus) approximately two MYA.
Although it is not known whether such selective sweep
resulted in the loss of some DRB1 allelic lineages in
chimpanzees, reduced genetic variation at the threeclass I loci in chimpanzees may have been linked to the
relatively small number of Patr-DRB1 allelic lineages.
Conclusions
A phylogenetic analysis of the HLA-DRB1 gene identified
two major groups of alleles, Groups A and B. Our findings
suggest that Group A is human-specific and has been
maintained by balancing selection in humans, while chim-
panzees may have lost their counterparts to these allelic
lineages due to different selective pressure. Some Group A
alleles can bind to peptides derived from human specific
pathogens and these showed a high frequency in popula-
tions outside Africa. Therefore, these alleles may have
increased in frequency after the Out-of-Africa event. Our
results imply that some of HLA Group A alleles may have
contributed to local adaptation of humans.
Perspective
In the present study, we identified a candidate human-
specific HLA-DRB1 allelic group. However, the sample
size of chimpanzees was smaller than that of humans.
Specifically, there were at least 88 chimpanzees used in
published studies [14,15,43-45], while the HLA-DRB1
alleles were detected in thousands of human individuals.
Therefore, there is possible sampling bias among chim-
panzees. The common chimpanzees are classified into at
least four subspecies, which are, Pan troglodytes troglodytes,
P. t. verus, P. t. ellioti, and P. t. schweinfurthii, in Mammal
Species of the World [46]. In addition to the common chim-
panzees, bonobo samples should also be included in the
phylogenetic analyses of DRB1 alleles. To exclude the possi-
bility that our finding is an artifact of sampling bias, we
plan to increase the sample size of chimpanzees in future
studies, which will help validate the present estimates.
In the present study, DRB1 alleles of rhesus monkeys
and crab-eating macaques formed a taxon-specific clade
with the exception of HLA-DRB4*01 sequences. All sam-
pled alleles in the two macaques formed a sister clade
with HLA Group A alleles in the ML tree but not with
HLA Group B alleles (Figure 1). In the future, the reason
why the DRB1 alleles of macaques formed a large mono-
phyletic group should be investigated.
It is difficult to verify that a molecule in HLA Group A
can recognize human-specific pathogens. In recent years,
there has been increasing information on peptide-HLA
binding. Future studies must examine the relationships
among HLA alleles, binding peptides, and pathogens in
order to elucidate the mechanisms by which modern
humans have adapted to a variety of environments around
the world.
The contribution of natural selection to local adaptation
in humans was evaluated from genomic data. The gen-
omic data provide a universal framework for understand-
ing human evolution and enable quantitative analysis
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molecular genetics techniques can shed light on some
important issues in physiological anthropology.
Additional files
Additional file 1: Figure S1. Synonymous substitutions occurring on
each branch of the ML tree for HLA Group A alleles in Figure 1. HLA-DRB1*09:01:02
was used as an outgroup sequence. The asterisk represents a synonymous
substitution at a singleton.
Additional file 2: Figure S2. Allelic frequency of HLA-DRB1 molecules
that bind HLA Group A-specific pathogens. The allelic frequency data was
obtained from the NCBI dbMHC database.
Abbreviations
bp: base pair; CDS: coding sequence; dN: number of non-synonymous
substitutions per non-synonymous site; dS: number of synonymous
substitutions per synonymous site; dSmax: maximum genetic distance at
synonymous sites; HKY: Hasegawa-Kishino-Yano; HLA: human leukocyte
antigen; HPV-11: human papillomavirus type 11; IBV: influenza B virus;
IEDB: Immune Epitope Database; KS: number of synonymous substitutions;
KSmax: maximum number of synonymous substitutions; LD: linkage
disequilibrium; LS: mean number of synonymous site; MHC: major
histocompatibility complex; ML: maximum likelihood; MYA: million years ago;
Ne: effective population size; NNI: nearest-neighbor-interchange;
PBR: peptide-binding region; TMRCA: time to most recent common ancestor.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YY carried out data analysis, and wrote the draft of manuscript. YS was the
primary supervisor. Both authors have read and approved the final manuscript.
Acknowledgements
This work was supported by Grant-in-Aid for Scientific Research on Innovative
Areas from the Ministry of Education, Culture, Sports, Science and Technology
of Japan (22133007). We owe special thanks to Drs. Naoyuki Takahata and Jun
Gojobori for providing valuable comments.
Author details
1Molecular and Genetic Epidemiology, Faculty of Medicine, University of
Tsukuba, 305-8575 Tsukuba, Ibaraki, Japan. 2Department of Evolutionary
Studies of Biosystems, The Graduate University for Advanced Studies
(SOKENDAI), 240-0193 Hayama, Kanagawa, Japan.
Received: 24 December 2013 Accepted: 27 May 2014
Published: 13 June 2014
References
1. Sabeti PC, Reich DE, Higgins JM, Levine HZP, Richter DJ, Schaffner SF,
Gabriel SB, Platko JV, Patterson NJ, Mcdonald GJ, Ackerman HC, Campbell
SJ, Altshuler D, Cooper R, Kwiatkowski D, Ward R, Lander ES: Detecting
recent positive selection in the human genome from haplotype
structure. Nature 2002, 419:832–837.
2. Hill AV: The immunogenetics of human infectious diseases. Annu Rev
Immunol 1998, 16:593–617.
3. The MHC sequencing consortium: Complete sequence and gene map of a
human major histocompatibility complex. Nature 1999, 401:921–923.
4. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC:
The foreign antigen binding site and T cell recognition regions of class I
histocompatibility antigens. Nature 1987, 329:512–518.
5. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC:
Three-dimensional structure of the human class II histocompatibility
antigen HLA-DR1. Nature 1993, 364:33–39.
6. Hughes AL, Nei M: Nucleotide substitution at major histocompatibility
complex class II loci: evidence for overdominant selection. Proc Natl Acad
Sci U S A 1989, 86:958–962.7. Hughes AL, Nei M: Pattern of nucleotide substitution at major
histocompatibility complex class I loci reveals overdominant selection.
Nature 1988, 335:167–170.
8. Takahata N, Satta Y, Klein J: Polymorphism and balancing selection at
major histocompatibility complex loci. Genetics 1992, 130:925–938.
9. Satta Y, O’hUigin C, Takahata N, Klein J: Intensity of natural selection at the
major histocompatibility complex loci. Proc Natl Acad Sci U S A 1994,
91:7184–7188.
10. Klein J, Sato A, Nikolaidis N: MHC, TSP, and the origin of species: from
immunogenetics to evolutionary genetics. Annu Rev Genet 2007, 41:281–304.
11. Takahata N, Nei M: Allelic genealogy under overdominant and
frequency-dependent selection and polymorphism of major
histocompatibility complex loci. Genetics 1990, 124:967–978.
12. Satta Y, O’hUigin C, Takahata N, Klein J: The synonymous substitution rate
of the major histocompatibility complex loci in primates. Proc Natl Acad
Sci U S A 1993, 90:7480–7484.
13. Muchmore EA: Chimpanzee models for human disease and
immunobiology. Immunol Rev 2001, 183:86–93.
14. Kenter M, Otting N, Anholts J, Jonker M, Schipper R, Bontrop RE: Mhc-DRB
diversity of the chimpanzee (Pan troglodytes). Immunogenetics 1992, 37:1–11.
15. Mayer WE, O’hUigin C, Zaleska-Rutczynska Z, Klein J: Trans-species origin of
Mhc-DRB polymorphism in the chimpanzee. Immunogenetics 1992, 37:12–23.
16. Bontrop RE, Otting N, de Groot NG, Doxiadis GGM: Major
histocompatibility complex class II polymorphisms in primates. Immunol
Rev 1999, 167:339–350.
17. Yasukochi Y, Satta Y: Current perspectives on the intensity of natural
selection of MHC loci. Immunogenetics 2013, 65:479–483.
18. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SGE: The
IMGT/HLA database. Nucleic Acids Res 2011, 39:D1171–D1176.
19. Robinson J, Waller MJ, Stoehr P, Marsh SGE: IPD-the immuno
polymorphism database. Nucleic Acids Res 2005, 33:D523–D526.
20. Satta Y: Balancing selection at HLA loci. In Proceedings of the 17th
Taniguchi Symposium. Edited by Takahata N. Tokyo: Japan Science Society
Press; 1992:111–131.
21. Kusaba M, Nishio T, Satta Y, Hinata K, Ockendon D: Striking sequence
similarity in inter- and intra-specific comparisons of class I SLG alleles
from Brassica oleracea and Brassica campestris: implications for the
evolution and recognition mechanism. Proc Natl Acad Sci U S A 1997,
94:7673–7678.
22. Yasukochi Y, Kurosaki T, Yoneda M, Koike H, Satta Y: MHC class II DQB diversity
in the Japanese black bear: Ursus thibetanus japonicus. BMC Evol Biol 2012,
12:230.
23. Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC:
Crystal structure of the human class II MHC protein HLA-DR1 complexed
with an influenza virus peptide. Nature 1994, 368:215–221.
24. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5:
molecular evolutionary genetics analysis using maximum likelihood,
evolutionary distance, and maximum parsimony methods. Mol Biol Evol
2011, 28:2731–2739.
25. Hasegawa M, Kishino H, Yano T: Dating of the human-ape splitting by a
molecular clock of mitochondrial DNA. J Mol Evol 1985, 22:160–174.
26. Zhang J, Rosenberg HF, Nei M: Positive Darwinian selection after gene
duplication in primate ribonuclease genes. Proc Natl Acad Sci U S A 1998,
95:3708–3713.
27. Jukes T, Cantor C: Evolution of protein molecules. In Mammalian Protein
Metabolism. Edited by Munro H. New York: Academic; 1969:21–132.
28. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette
A, Peters B: The immune epitope database 2.0. Nucleic Acids Res 2010,
38:D854–D862.
29. Meyer D, Single R, Mack S, Lancaster A, Nelson M, Erlich H, Fernandez-Vina
M, Thomson G: Single locus polymorphism of classical HLA genes. In
Immunobiolology of the Human MHC: Proceedings of the 13th International
Histocompatibility Workshop and Conference, Volume I. Edited by Hansen JA.
Seattle, WA: IHWG Press; 2007:653–704.
30. Klein J: Origin of major histocompatibility complex polymorphism: the
trans-species hypothesis. Hum Immunol 1987, 19:155–162.
31. Klein J, Sato A, Nagl S, O’hUigin C: Molecular trans-species polymorphism.
Annu Rev Ecol Syst 1998, 29:1–21.
32. Satta Y, Hickerson M, Watanabe H, O’hUigin C, Klein J: Ancestral population
sizes and species divergence times in the primate lineage on the basis
of intron and BAC end sequences. J Mol Evol 2004, 59:478–487.
Yasukochi and Satta Journal of Physiological Anthropology 2014, 33:14 Page 9 of 9
http://www.jphysiolanthropol.com/content/33/1/1433. Steiper ME, Young NM: Primate molecular divergence dates. Mol
Phylogenet Evol 2006, 41:384–394.
34. Scally A, Dutheil JY, Hillier LW, Jordan GE, Goodhead I, Herrero J, Hobolth A,
Lappalainen T, Mailund T, Marques-Bonet T, McCarthy S, Montgomery SH,
Schwalie PC, Tang YA, Ward MC, Xue Y, Yngvadottir B, Alkan C, Andersen
LN, Ayub Q, Ball EV, Beal K, Bradley BJ, Chen Y, Clee CM, Fitzgerald S, Graves
TA, Gu Y, Heath P, Heger A, et al: Insights into hominid evolution from the
gorilla genome sequence. Nature 2012, 483:169–175.
35. Takahata N: Evolutionary genetics of human paleo-populations. In
Mechanisms of molecular evolution. Edited by Takahata N, Clark A.
Sunderland, Massachusetts: Sinauer Associates; 1993:1–21.
36. Takahata N, Satta Y, Klein J: Divergence time and population size in the
lineage leading to modern humans. Theor Popul Biol 1995, 48:198–221.
37. Satta Y: Comparison of DNA and protein polymorphisms between
humans and chimpanzees. Genes Genet Syst 2001, 76:159–168.
38. Kim HL, Igawa T, Kawashima A, Satta Y, Takahata N: Divergence,
demography and gene loss along the human lineage. Philos Trans R Soc
Lond B Biol Sci 2010, 365:2451–2457.
39. Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP: CD46:
expanding beyond complement regulation. Trends Immunol 2004,
25:496–503.
40. Guiso N: Bordetella pertussis and pertussis vaccines. Clin Infect Dis 2009,
49:1565–1569.
41. Osterhaus A, Rimmelzwaan G, Martina B, Bestebroer T, Fouchier R: Influenza
B virus in seals. Science 2000, 288:1051–1053.
42. De Groot NG, Otting N, Doxiadis GGM, Balla-Jhagjhoorsingh SS, Heeney JL,
van Rood JJ, Gagneux P, Bontrop RE: Evidence for an ancient selective
sweep in the MHC class I gene repertoire of chimpanzees. Proc Natl Acad
Sci U S A 2002, 99:11748–11753.
43. Gyllensten UB, Sundvall M, Erlich HA: Allelic diversity is generated by
intraexon sequence exchange at the DRB1 locus of primates. Proc Natl
Acad Sci U S A 1991, 88:3686–3690.
44. Bak EJ, Ishii Y, Omatsu T, Kyuwa S, Tetsuya T, Hayasaka I, Yoshikawa Y:
Identification and analysis of MHC class II DRB1 (Patr-DRB1) alleles in
chimpanzees. Tissue Antigens 2006, 67:134–142.
45. De Zorzi M, Caggiari L, Ahlenstiel G, Rehermann B, De Re V: Description of
two new major histocompatibility complex (MHC) class II DRB1
[Pan troglodytes (Patr)-DRB1] alleles. Tissue Antigens 2008, 71:490–492.
46. Wilson D, Reeder D: Mammal Species of the World: A Taxonomic and Geographic
Reference. 3rd edition. Baltimore: Johns Hopkins University Press; 2005.
doi:10.1186/1880-6805-33-14
Cite this article as: Yasukochi and Satta: A human-specific allelic group
of the MHC DRB1 gene in primates. Journal of Physiological Anthropology
2014 33:14.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
